UBS Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$84.6M Buy
+175,200
New +$46.5M 0.01% 1245
2026
Q1
Sell
-189,900
Closed -$31.6M 11307
2025
Q4
$31.6M Sell
189,900
-171,023
-47% -$28.6M 0.01% 2120
2025
Q3
$70.7M Buy
360,923
+359,000
+18,669% +$59M 0.01% 1311
2025
Q2
$174K Buy
+1,923
New +$152K ﹤0.01% 6814

Other funds holding ALAB

UBS Group's ALAB Position: Q2 2026 in Review

UBS Group reduced its Astera Labs (ALAB) stake by 44% in Q2 2026, selling an estimated $170M and leaving 802,024 shares worth $387M. The position accounts for 0.05% of the portfolio, ranked #385.

UBS Group first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • UBS Group held 802,024 shares of Astera Labs worth $387M as of Q2 2026.
  • UBS Group sold 640,554 Astera Labs shares in Q2 2026, an estimated $170M.
  • Astera Labs made up 0.05% of UBS Group's portfolio in Q2 2026, its #385 holding.
  • UBS Group first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.